A Case of Nivolumab-Induced Myositis. (18th November 2016) - Fox, Eric
Abstract : Nivolumab (Opdivo) is a monoclonal antibody classified as an immune modulator. A case is presented of nivolumab-induced myositis, an unlisted side effect.